TD Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-95,435
| Closed | -$1.68M | – | 1582 |
|
|
2021
Q3 | $1.68M | Sell |
95,435
-214,820
| -69% | -$3.77M | ﹤0.01% | 1134 |
|
|
2021
Q2 | $2.03M | Sell |
310,255
-1,424
| -0.5% | -$9.31K | ﹤0.01% | 1089 |
|
|
2021
Q1 | $3.34M | Buy |
311,679
+17,520
| +6% | +$188K | ﹤0.01% | 943 |
|
|
2020
Q4 | $4.33M | Buy |
294,159
+52,792
| +22% | +$776K | 0.01% | 829 |
|
|
2020
Q3 | $3.42M | Buy |
241,367
+164,792
| +215% | +$2.33M | ﹤0.01% | 806 |
|
|
2020
Q2 | $617K | Buy |
+76,575
| New | +$617K | ﹤0.01% | 1175 |
|